Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Antibiotics (Basel, Switzerland)|July 29, 2023
Fluorescence Microscopy: Determination of Meropenem Activity against <i>Klebsiella pneumoniae</i>Kamilla N Alieva, Maria V Golikova, Anastasia A Kuznetsova, et al.
Frontiers in Surgery|July 25, 2025
Case report of successful treatment of patient with ruptured celiac artery aneurysmI A Semenenko, V A Yumasheva, N Alieva, et al.
Antibiotiki I Khimioterapiia = Antibiotics and Chemoterapy [Sic]|March 15, 2018
Concentration-Dependent Enrichment of Linezolid-Resistant Staphylococcus aureus in an in vitro Dynamic ModelK N Alieva, E N Strukova, M V Golikova, et al.
The Journal of Antimicrobial Chemotherapy|April 28, 2021
Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycinStephen H Zinner, Kamilla N Alieva, Maria V Golikova, et al.
The Journal of Antibiotics|January 20, 2018
Time inside the mutant selection window as a predictor of staphylococcal resistance to linezolidKamilla N Alieva, Elena N Strukova, Maria V Golikova, et al.
Journal of Chemotherapy (Florence, Italy)|January 22, 2019
Concentration-dependent enrichment of resistant Enterococcus faecium exposed to linezolid in an in vitro dynamic modelKamilla N Alieva, Maria V Golikova, Yury A Portnoy, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing <i>Klebsiella pneumoniae</i>Maria V Golikova, Elena N Strukova, Kamilla N Alieva, et al.
Antibiotics (Basel, Switzerland)|December 23, 2023
Comparative Meropenem Pharmacodynamics and Emergence of Resistance against Carbapenem-Susceptible Non-Carbapenemase-Producing and Carbapenemase-Producing Enterobacterales: A Pharmacodynamic Study in a Hollow-Fiber Infection ModelMaria V Golikova, Kamilla N Alieva, Elena N Strukova, et al.
Biomedicines|June 24, 2022
<i>Klebsiella pneumoniae</i> Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration RatioMaria V Golikova, Kamilla N Alieva, Alla V Filimonova, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Long-term treatment of morphologically verified myocarditis: successes and probable errors. Case report]O V Blagova, I N Alieva, V A Kulikova, et al.
Pageof 3